Product Images Drospirenone And Ethinyl Estradiol

This text describes a likelihood chart of developing a VTE (Venous Thromboembolism), which is a type of blood clot, in non-pregnant women who use or do not use COC (combined oral contraceptives) and pregnant or postpartum women. The chart shows the number of women out of 10,000 women years who develop a blood clot in each group. The pregnancy data is based on actual duration and the assumption that the duration is nine months, with a rate of 7 to 27 per 10,000 WY.*

Drospirenone Ethinyl estadiol is a combination of two hormones used for birth control. Drospirenone is a type of progestin and ethinyl estradiol is a type of estrogen. It works by preventing ovulation, thickening cervical mucus to prevent sperm from reaching the egg, and thinning the lining of the uterus to prevent implantation.*

This text is not available as it contains misspelled words and unclear information.*

This text provides blood clot ranges for non-pregnant women, non-COC users, pregnant women, and postpartum women (up to 12 weeks only) based on the number of women who had a blood clot out of 10,000 Women Years (WY). However, the pregnancy data's rate is based on the actual duration (not assumed) of pregnancy in reference studies but also based on model assumption with a rate from 7 to 27 per 10,000 WY.*

The text appears to be a list of pharmaceutical-related information, including the name of a drug (Drospirenone and Ethinyl Estradiol Tablets), its dosage (3mg/0.02mg), and some technical details about the drug's composition and packaging. Without further context, it is difficult to provide a more detailed description.*